Ryanair 2016 Annual Report Download - page 190

Download and view the complete annual report

Please find page 190 of the 2016 Ryanair annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 205

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • 178
  • 179
  • 180
  • 181
  • 182
  • 183
  • 184
  • 185
  • 186
  • 187
  • 188
  • 189
  • 190
  • 191
  • 192
  • 193
  • 194
  • 195
  • 196
  • 197
  • 198
  • 199
  • 200
  • 201
  • 202
  • 203
  • 204
  • 205

190
The beneficial interests as at March 31, 2016, 2015 and 2014 of the directors in office at March 31, 2016 and of
their spouses and dependent children in the share capital of the Company are as follows:
No. of Shares at March 31,
2016
2015
2014
David Bonderman
7,535,454
7,680,671
7,655,671
Michael Cawley
756,198
615,588
Kyran McLaughlin
225,000
225,000
200,000
Howard Millar
390,000
Dick Milliken
9,750
10,000
10,000
Michael O’Leary
50,096,725
51,381,256
51,081,256
James Osborne
302,500
310,256
310,256
Louise Phelan
6,825
7,000
7,000
(ii) Share options
The share options held by each director in office at the end of fiscal 2016 were as follows:
No. of Options at March 31,
2016
2015
2014
David Bonderman (b) (c)
30,000
30,000
25,000
Michael Cawley (b)
30,000
30,000
John Leahy (a)
30,000
Charles McCreevy (b)
30,000
30,000
Declan McKeon (b)
30,000
30,000
Kyran McLaughlin (b)
30,000
30,000
Howard Millar (a)
30,000
Dick Milliken (b)
30,000
30,000
Michael O'Leary (d)
5,000,000
5,000,000
Julie O’Neill (b)
30,000
30,000
James Osborne (b) (c)
30,000
30,000
25,000
Louise Phelan (b)
30,000
30,000
(a) These options were granted to these directors at an exercise price of €11.38 (the market value at the date of grant) during the
2016 fiscal year and are exercisable between August 2019 and August 2021 subject to the director still being a non-executive
director of the Company through April 30, 2019.
(b) These options were granted to these directors at an exercise price of €6.25 (the market value at the date of grant) during the
2015 fiscal year and are exercisable between June 2019 and July 2022 subject to the director still being a non-executive director of
the Company through April 30, 2019.
(c) These 25,000 options were granted to these directors at an exercise price of €4.96 (the market value at the date of grant) during
the 2008 fiscal year and were exercisable between June 2012 and June 2014.
(d) These options were granted to Mr. O’Leary during fiscal 2015 at an exercise price of €8.345 (the market value at the date of
grant) and are exercisable between September 2019 and November 2021 subject to him still being an employee of the Company
through July 31, 2019.
In the 2016 fiscal year the Company incurred total share-based compensation expense of €1.6 million (2015:
€0.06; 2014: €nil million) in relation to directors.